JPRN-UMIN000047536招募中未知
Biochemical adaptive radiation therapy based on prostate-specific antigen response in salvage radiation therapy for postoperative biochemical failure of prostate cancer. - Biochemical Adaptive Salvage Radiation Therapy for biochemical failure after radical prostatectomy.
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •1.Prior exposure to any anti-cancer drug and/or hormonal agents. 2.History of pelvic irradiation. 3.Active overlap cancer
研究者
相似试验
尚未招募
不适用
Towards Response guided ADAptive Radiotherapy for organ preserving treatment of intermediate risk rectal cancer: a phase I dose finding trialrectal carcinomarectal cancer100179901001799110017998NL-OMON51912niversitair Medisch Centrum Utrecht45
招募中
不适用
Towards Response guided ADAptive Radiotherapy for organ preserving treatment of intermediate risk rectal cancer: a phase I dose finding trialrectal cancerNL-OMON22916MC Utrecht45
进行中（未招募）
1 期
START-NET: A randomized clinical trial to compare personalized vs non-personalized radionuclide therapy with 177Lu-DOTATOCPatients with SSTR+, advanced, progressive NET Grade 1-3 of any origin for whom Peptide-receptor radionuclide therapy, PRRT, is considered the mostappropriate treatment option in relation to other approved or available investigational agents for the specific tumor subtype.MedDRA version: 21.0Level: LLTClassification code 10062476Term: Neuroendocrine tumorSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2021-002218-15-SERegion Skåne300
已完成
不适用
adaptive radiotherapy in prostate cancer patientsprostate cancer.Dysplasia of prostateN42.3IRCT20181006041257N1Vice Chancellor for Research and Technology40
尚未招募
2 期
Adaptive Radiotherapy for Head and Neck Cancer: Feasibility and Clinical ImplicationsHead and Neck CancerCancer - Head and neckACTRN12615000771550Susan Mincham20